Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

被引：0

作者：

Kirschbaum, Mark ^{[1
]}

Gojo, Ivana ^{[2
]}

Goldberg, Stuart L. ^{[3
]}

Kujawski, Lisa ^{[4
]}

Atallah, Ehab ^{[5
]}

Marks, Peter ^{[6
]}

Garcia-Vargas, Jose ^{[7
]}

Rizvi, Syed ^{[7
]}

Di Gravio, Donna ^{[7
]}

Ahern, Janet ^{[7
]}

Issa, Jean-Pierre ^{[8
]}

机构：

[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA

[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA

[3] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[6] Yale Univ, Sch Med, New Haven, CT USA

[7] Merck & Co Inc, Upper Gwynedd, PA USA

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1250 / 1250

页数：1

共 50 条

[1] Vorinostat in Combination with Decitabine for the Treatment of Relapsed or Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS): A Phase I, Dose-Escalation Study
Kirschbaum, Mark
Gojo, Ivana
Goldberg, Stuart L.
Kujawski, Lisa
Atallah, Ehab
Marks, Peter
Di Gravio, Donna
Pyle, Lisa
Rizvi, Syed
Issa, Jean-Pierre J.
BLOOD, 2009, 114 (22) : 824 - 825
[2] Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Garcia-Manero, Guillermo
Tambaro, Francesco Paolo
Bekele, Nebiyou B.
Yang, Hui
Ravandi, Farhad
Jabbour, Elias
Borthakur, Gautam
Kadia, Tapan M.
Konopleva, Marina Y.
Faderl, Stefan
Cortes, Jorge E.
Brandt, Mark
Hu, Yumin
Mccue, Deborah
Newsome, Willie Mae
Pierce, Sherry R.
de Lima, Marcos
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2204 - 2210
[3] Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
Ritchie, Ellen K.
Feldman, Eric J.
Christos, Paul J.
Rohan, Sarah D.
Lagassa, Catherine B.
Ippoliti, Cindy
Scandura, Joseph M.
Carlson, Karen
Roboz, Gail J.
LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2003 - 2007
[4] Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia
Liesveld, Jane L.
O'Dwyer, Kristen
Becker, Michael W.
Mulford, Deborah
Walker, Alison
Chen, Rui
Bechelli, Jeremy
Rosell, Karen
Jordan, Craig T.
Minhajuddin, Mohammad
Phillips, Gordon L., II
BLOOD, 2012, 120 (21)
[5] A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
Daver, N.
Kantarjian, H.
Ravandi, F.
Estey, E.
Wang, X.
Garcia-Manero, G.
Jabbour, E.
Konopleva, M.
O'Brien, S.
Verstovsek, S.
Kadia, T.
Dinardo, C.
Pierce, S.
Huang, X.
Pemmaraju, N.
Diaz-Pines-Mateo, M.
Cortes, J.
Borthakur, G.
LEUKEMIA, 2016, 30 (02) : 268 - 273
[6] A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
N Daver
H Kantarjian
F Ravandi
E Estey
X Wang
G Garcia-Manero
E Jabbour
M Konopleva
S O'Brien
S Verstovsek
T Kadia
C Dinardo
S Pierce
X Huang
N Pemmaraju
M Diaz-Pines-Mateo
J Cortes
G Borthakur
Leukemia, 2016, 30 : 268 - 273
[7] Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Garcia-Manero, Guillermo
Tambaro, Francesco Paolo
Bekele, Nebiyou
Yang, Rui
Ravandi, Farhad
Jabbour, Elias
Borthakur, Gautam
Kadia, Tapan
Konopleva, Marina
Faderl, Stefan
Cortes, Jorge E.
Brandt, Mark
Hu, Yumin
McCue, Deborah
Newsome, Willie Mae
Pierce, Sherry
DeLima, Marcos
Kantarjian, Hagop M.
BLOOD, 2011, 118 (21) : 346 - 347
[8] Phase 2 study of decitabine in combination with tretinoin in myelodysplastic syndromes and acute myelogenous leukemia
Klimek, V.
Dolezal, E. D.
Jurcic, J. G.
Devlin, S.
Zikaras, K.
Park, J. H.
Rosenblat, T. L.
Nimer, S. D.
LEUKEMIA RESEARCH, 2013, 37 : S153 - S153
[9] A Phase I Study Using Single Agent Birinapant in Patients with Relapsed Myelodysplastic Syndrome and Acute Myelogenous Leukemia
Frey, Noelle V.
Luger, Selina
Mangan, James
Zebrowski, Alexis
Loren, Alison W.
Minderman, Hans
Baird, John
Porter, David L.
Hexner, Elizabeth O.
Kumar, Anita J.
Luskin, Marlise R.
Perl, Alexander E.
Carroll, Martin
BLOOD, 2014, 124 (21)
[10] Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
Daver, Naval
Kantarjian, Hagop
Garcia-Manero, Guillermo
Jabbour, Elias
Borthakur, Gautam
Brandt, Mark
Pierce, Sherry
Vaughan, Kenneth
Ning, Jing
Gonzalez, Graciela M. Nogueras
Patel, Keyur
Jorgensen, Jeffery
Pemmaraju, Naveen
Kadia, Tapan
Konopleva, Marina
Andreeff, Michael
DiNardo, Courtney
Cortes, Jorge
Ward, Renee
Craig, Adam
Ravandi, Farhad
HAEMATOLOGICA, 2017, 102 (10) : 1709 - 1717

← 1 2 3 4 5 →